[ad_1] Newswise — Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce that Selwyn M. Vickers, MD, FACS, President and Chief Executive Officer of MSK, and Andrea...
[ad_1] Newswise — Memorial Sloan Kettering Cancer Center (MSK) announced today that the U.S. Food and Drug Administration (FDA) has approved the oral MEK inhibitor drug cobimetinib (Cotellic®) for the...